Cannlabs Inc
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consu… Read more
Cannlabs Inc (CANL) - Total Assets
Latest total assets as of December 2022: $3.25 Million USD
Based on the latest financial reports, Cannlabs Inc (CANL) holds total assets worth $3.25 Million USD as of December 2022.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Cannlabs Inc - Total Assets Trend (2009–2022)
This chart illustrates how Cannlabs Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Cannlabs Inc - Asset Composition Analysis
Current Asset Composition (December 2022)
Cannlabs Inc's total assets of $3.25 Million consist of 70.8% current assets and 29.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 20.0% |
| Accounts Receivable | $763.22K | 23.5% |
| Inventory | $886.22K | 27.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2009–2022)
This chart illustrates how Cannlabs Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cannlabs Inc's current assets represent 70.8% of total assets in 2022, an increase from 26.3% in 2009.
- Cash Position: Cash and equivalents constituted 20.0% of total assets in 2022, down from 26.3% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2009.
- Asset Diversification: The largest asset category is inventory at 27.3% of total assets.
Cannlabs Inc Competitors by Total Assets
Key competitors of Cannlabs Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Cannlabs Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Cannlabs Inc generates 1.35x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Cannlabs Inc generates $ 26.75 in net profit.
Cannlabs Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 23.93 | 52.00 | 0.00 |
| Quick Ratio | 14.71 | 31.41 | 0.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.20 Million | $ 1.99 Million | $ -54.41K |
Cannlabs Inc - Advanced Valuation Insights
This section examines the relationship between Cannlabs Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 25.22 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 8.9% |
| Total Assets | $3.25 Million |
| Market Capitalization | $0.92 USD |
Valuation Analysis
Below Book Valuation: The market values Cannlabs Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Cannlabs Inc's assets grew by 8.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Cannlabs Inc (2009–2022)
The table below shows the annual total assets of Cannlabs Inc from 2009 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | $3.25 Million | +8.93% |
| 2021-12-31 | $2.98 Million | +10.39% |
| 2020-12-31 | $2.70 Million | +23.49% |
| 2019-12-31 | $2.19 Million | +66.04% |
| 2018-12-31 | $1.32 Million | 0.00% |
| 2017-12-31 | $1.32 Million | 0.00% |
| 2016-12-31 | $1.32 Million | 0.00% |
| 2014-12-31 | $1.32 Million | +527.79% |
| 2013-12-31 | $209.88K | +555.89% |
| 2012-12-31 | $32.00K | -63.38% |
| 2011-12-31 | $87.38K | -42.73% |
| 2010-12-31 | $152.58K | -19.83% |
| 2009-12-31 | $190.32K | -- |